Clinical Trial Update: Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Bosentan in sickle cell disease patients with pulmonary hypertension was terminated, with the update focusing on efficacy and safety ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sickle Cell Disease

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 3 | Status: TERMINATED